Carvedilol
Product Images NDC 42254-162

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 42254-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol Structure (E843534e 47a2 46e3 92bb D079467be606 01)

Carvedilol Structure (E843534e 47a2 46e3 92bb D079467be606 01)
Chemical structure of carvedilol, showing the molecular arrangement of atoms including phenyl groups, ether linkages, and hydroxyl groups characteristic of this active ingredient.*
FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (E843534e 47a2 46e3 92bb D079467be606 02)

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (E843534e 47a2 46e3 92bb D079467be606 02)
A line graph depicting percent mortality over a 24-month period, comparing Carvedilol treatment to placebo. The vertical axis shows mortality percentage from 0 to 30%, and the horizontal axis represents time in months from 0 to 24. The graph indicates a lower mortality with Carvedilol compared to placebo, with a statistical significance noted at P = 0.03.*
FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (E843534e 47a2 46e3 92bb D079467be606 03)

Figure 2. Effects On Mortality For Subgroups In Capricorn (E843534e 47a2 46e3 92bb D079467be606 03)
A forest plot showing hazard ratios with confidence intervals for various patient subgroups related to Carvedilol treatment. The subgroups include age, sex, time post-myocardial infarction, prior medication, Killip classification, thrombolytic therapy, PTCA for MI, history of CHF, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure. Each subgroup's hazard ratio is plotted along the x-axis scale ranging from 0.4 to 1.3.*
FDA Label Image

Carvedilol 3.125mg (E843534e 47a2 46e3 92bb D079467be606 04)

Carvedilol 3.125mg (E843534e 47a2 46e3 92bb D079467be606 04)
Label for Carvedilol 3.125 mg tablets manufactured by Aurolife Pharma LLC, Dayton, NJ, and distributed by Physician Partner. The label states the tablets are film-coated, white to off-white, oval shaped, debossed with "E" and "01." It includes storage instructions and a note indicating prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.